Use of Nonlinear Mixed Effect Modeling for the Meta‐Analysis of Preclinical Pharmacokinetic Data: Application to S 20342 in the Rat
- 1 May 2000
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 89 (5) , 603-613
- https://doi.org/10.1002/(sici)1520-6017(200005)89:5<603::aid-jps6>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development. I: Interspecies Allometric ScalingJournal of Pharmacokinetics and Biopharmaceutics, 1997
- The Use of Population Pharmacokinetics in Drug DevelopmentClinical Pharmacokinetics, 1996
- Application of Sparse Sampling Approaches in Rodent Toxicokinetics: A Prospective ViewDrug Information Journal, 1994
- Sparse data analysisEuropean Journal of Drug Metabolism and Pharmacokinetics, 1993
- Forecasting individual pharmacokineticsClinical Pharmacology & Therapeutics, 1979